Skip to main content

Advertisement

SpringerLink
Log in

Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Lower nadir CD4 cell counts and higher HIV viral loads are associated with increased risks of adverse events in the progression of HIV disease. In cases where medical records are inaccessible or incomplete, little evidence is available regarding whether nadir CDR cell count or HIV viral load is reliably reported in any patient population. We compare survey data collected from 207 HIV-infected individuals detained in San Francisco jails to data collected from electronic medical records (EMR) kept by the jails and community health providers. The sensitivity of self-reported nadir CD4 cell count less than 200 was 82 % [95 % confidence interval (CI) 68, 88], and the sensitivity of reporting an undetectable most recent HIV viral load was 93 % (95 % CI 84, 97). This suggests that in a highly socially marginalized population, nadir CD4 cell count and most recent HIV viral load are recalled accurately when compared to EMR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV/AIDS. 2012;4:117–24.

    PubMed Central  PubMed  Google Scholar 

  2. Cohen MS, Chen YQ, McCauly M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365(6):493–505.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Palepu A, Yip B, Miller C, et al. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS. 2001;15(3):423–4.

    Article  CAS  PubMed  Google Scholar 

  4. Lucas MG, Chaisson ER, Moore DR. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2):81–7.

    Article  CAS  PubMed  Google Scholar 

  5. Moreno A, Perez-Elias MJ, Casado JL, et al. Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes. AIDS. 2001;15:1068–70.

    Article  CAS  PubMed  Google Scholar 

  6. Jensen-Fangel S, Pedersen L, Pedersen C, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis. 2002;35(12):1541–8.

    Article  PubMed  Google Scholar 

  7. Palepu A, Tyndall MW, Li K, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003;80(4):667–75.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Mellins CA, Havens JF, McCaskill EO, Leu CS, Brudney K, Chesney MA. Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers. Psychol Health Med. 2002;7(4):451–60.

    Article  Google Scholar 

  9. Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157(2):248–54.

    Article  CAS  PubMed  Google Scholar 

  10. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–94.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Boutwell A, Rich JD. HIV Infection behind Bars. Clin Infect Dis. 2004;38:1761–3.

    Article  PubMed  Google Scholar 

  12. Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96(6):974–8.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Cunningham CO, Sohler NL, Heller D, Selwyn PA. Health care access and utilization patterns in unstably housed HIV-infected individuals in New York City. AIDS Patient Care STDS. 2005;19(10):690–5.

    Article  PubMed  Google Scholar 

  14. Tsao JCI, Soto T. Pain in persons living with HIV and comorbid psychological and substance use disorders. Clin J Pain. 2010;25(4):307–12.

    Article  Google Scholar 

  15. Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Cederfjäll C, Langius-Eklöf A, Lidman K, Wredling R. Self-reported adherence to antiretroviral treatment and degree of sense of coherence in a group of HIV-infected patients. AIDS Patient Care STDS. 2002;16(12):609–16.

    Article  PubMed  Google Scholar 

  17. Kalichman SC, Rompa D, Cage M. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. Int J STD AIDS. 2000;11(9):579–85.

    Article  CAS  PubMed  Google Scholar 

  18. Cunningham WE, Rana HM, Shapiro MF, Hays RD. Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease. J Clin Epidemiol. 1997;50(7):829–35.

    Article  CAS  PubMed  Google Scholar 

  19. Kinsler JJ, Cunningham WE, Mohanty S, Wong MD. Are medical records a more reliable and valid source of CD4 count, viral load, and outpatient visit data than self-reports? A comparison with electronic medical records as the gold standard. Health Serv Outcomes Res Methodol. 2008;8(4):187–200.

    Article  Google Scholar 

  20. Fisher DG, Reynolds GL, Jaffe A, Johnson ME. Reliability, sensitivity and specificity of self-report of HIV test results. AIDS Care. 2007;19(5):692–6.

    Article  CAS  PubMed  Google Scholar 

  21. Sohler NL, Coleman SM, Cabral H, Naar-King S, Tobias C, Cunningham CO. Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the United States? AIDS Patient Care STDS. 2009;23(10):837–43.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Johnson ME, Fisher DG, Montoya I, et al. Reliability and validity of not-in-treatment drug users’ follow-up self-reports. AIDS Behav. 2000;4(4):373–80.

    Article  Google Scholar 

  23. Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8(2):161–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunisation practices. MMWR. 2012;61(40):816–9.

    Google Scholar 

  25. Lang S, Mary-Krause M, Simon A, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012;55(4):600–7.

    Article  CAS  PubMed  Google Scholar 

  26. Valcour V, Yee P, Williams AE, et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii aging with HIV cohort. J Neurovirol. 2006;12(5):387–91.

    Article  PubMed  Google Scholar 

  27. Boulassel M-R, Chomont N, Pai NP, Gilmore N, Sékaly R-P, Routy J-P. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53(1):29–32.

    Article  CAS  PubMed  Google Scholar 

  28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.

    Article  CAS  PubMed  Google Scholar 

  29. Maclure M, Willett W. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol. 1987;126(17):161–9.

    Article  CAS  PubMed  Google Scholar 

  30. Müller R, Büttner P. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.

    Article  PubMed  Google Scholar 

  31. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.

    PubMed  Google Scholar 

  32. Myers J, Kang Dufour M-S. Continuity of care for HIV-infected inmates: The San Francisco navigator project [poster]. Third annual academic & health policy conference on correctional health. Atlanta; 2012.

  33. Cohen C. Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen. HIV Clin Trials. 2009;10(2):116–24.

    Article  PubMed  Google Scholar 

  34. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.

    PubMed  Google Scholar 

  35. Cortina JM. What is coefficient alpha? an examination of theory and applications. J App Psych. 1993;78(1):98–104.

    Article  Google Scholar 

  36. Mariller M, Abramson D, Sobieszczyk M. The validity of self-reported clinical markers and medication regimens: a pilot study. Community health advisory and information network report 2004-06. Columbia University: Mailman School of Public Health: New York; 2006.

  37. Calsyn RJ, Allen G, Morse G, Smith R, Tempelhoff B. Can you trust self-report data provided by homeless mentally ill individuals? Eval Rev. 1993;17(3):353–66.

    Article  Google Scholar 

  38. Calsyn R, Morse G. Reliability and validity of self-report data of homeless mentally ill individuals. Eval Program Plan. 1997;20(1):47–54.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank Becky Packard and Mark Morewitz for their assistance in collecting the survey data. The parent study, Navigator Case Management/HIV+ Inmates, is supported by the National Institutes of Health and the National Institute on Drug Abuse, Grant Number R01DA027209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

  1. Department of Medicine, Center for AIDS Prevention Studies, University of California – San Francisco, 550 16th St., 3rd Floor, UCSF Mailcode 0886, San Francisco, CA, 94158, USA

    Timothy R. Buisker, Mi-Suk Kang Dufour & Janet J. Myers

  2. Division of Epidemiology, School of Public Health, University of California – Berkeley, Berkeley, CA, USA

    Timothy R. Buisker

Authors
  1. Timothy R. Buisker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mi-Suk Kang Dufour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janet J. Myers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy R. Buisker.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buisker, T.R., Dufour, MS.K. & Myers, J.J. Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults. AIDS Behav 19, 2108–2116 (2015). https://doi.org/10.1007/s10461-015-1018-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-015-1018-x

Keywords

Search

Navigation